1. AB0213 A Stabilised-Release Neuropeptide Functions as A Novel Cutaneous Anti-Fibrotic Agent. (10th June 2014) Authors: Woloszynek, J.; Etzel, K.; Vernes, J.; McIntosh, D.; Moore, C.; Haq, M.; Lopez, H.; Haq, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0214 A Stabilized Neuropeptide Immunotherapy Abrogates Bleomycin-Induced Pulmonary Fibrosis. (10th June 2014) Authors: Woloszynek, J.; Etzel, K.; Vernes, J.; McIntosh, D.; Moore, C.; Haq, M.; Lopez, H.; Haq, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of On-trial Quality Assurance for the SPARC Clinical Trial using Novel Peer-review Methodology. Issue 6 (June 2018) Authors: Holyoake, D.; Robinson, M.; Grose, D.; McIntosh, D.; Radhakrishna, G.; Sebag-Montefiore, D.; Hawkins, M. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1405 Feasibility study of fiducial markers in oesophageal cancer radiotherapy. (April 2019) Authors: Morton, A.; McIntosh, D.; Currie, S.; Stanley, A.J.; Paterson, S.; Grose, D.; Marashi, H.; MacLaren, V. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0224 A placebo-controlled phase II study of hyperimmune caprine serum as potential treatment for established diffuse cutaneous systemic sclerosis. (23rd January 2014) Authors: Quillinan, N.; McIntosh, D.; Haq, S.; Denton, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗